Annual Total Liabilities
$51.76 B
-$5.30 B-9.28%
March 31, 2024
Summary
- As of February 7, 2025, TAK annual total liabilities is $51.76 billion, with the most recent change of -$5.30 billion (-9.28%) on March 31, 2024.
- During the last 3 years, TAK annual total liabilities has fallen by -$18.35 billion (-26.18%).
- TAK annual total liabilities is now -33.31% below its all-time high of $77.62 billion, reached on March 31, 2019.
Performance
TAK Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$48.95 B
-$4.62 B-8.62%
December 1, 2024
Summary
- As of February 7, 2025, TAK quarterly total liabilities is $48.95 billion, with the most recent change of -$4.62 billion (-8.62%) on December 1, 2024.
- Over the past year, TAK quarterly total liabilities has dropped by -$4.62 billion (-8.62%).
- TAK quarterly total liabilities is now -39.12% below its all-time high of $80.41 billion, reached on June 30, 2019.
Performance
TAK Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
TAK Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.3% | -8.6% |
| 3 y3 years | -26.2% | -14.2% |
| 5 y5 years | -33.3% | -30.2% |
TAK Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -26.2% | at low | -23.5% | at low |
| 5 y | 5-year | -33.3% | at low | -34.6% | at low |
| alltime | all time | -33.3% | +1211.6% | -39.1% | +622.8% |
Takeda Pharmaceutical Company Limited Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $48.95 B(-8.6%) |
| Sep 2024 | - | $53.58 B(+2.3%) |
| Jun 2024 | - | $52.37 B(+1.2%) |
| Mar 2024 | $51.76 B(-9.3%) | $51.76 B(-2.4%) |
| Dec 2023 | - | $53.04 B(+1.6%) |
| Sep 2023 | - | $52.22 B(-3.9%) |
| Jun 2023 | - | $54.36 B(-4.7%) |
| Mar 2023 | $57.06 B(-7.1%) | $57.06 B(+2.1%) |
| Dec 2022 | - | $55.89 B(+2.5%) |
| Sep 2022 | - | $54.51 B(-3.9%) |
| Jun 2022 | - | $56.72 B(-7.6%) |
| Mar 2022 | $61.40 B(-12.4%) | $61.40 B(-4.1%) |
| Dec 2021 | - | $64.02 B(-1.0%) |
| Sep 2021 | - | $64.64 B(-3.7%) |
| Jun 2021 | - | $67.11 B(-4.3%) |
| Mar 2021 | $70.12 B(-6.4%) | $70.12 B(-5.4%) |
| Dec 2020 | - | $74.14 B(+1.1%) |
| Sep 2020 | - | $73.32 B(-0.4%) |
| Jun 2020 | - | $73.64 B(-1.7%) |
| Mar 2020 | $74.89 B(-3.5%) | $74.89 B(+0.0%) |
| Dec 2019 | - | $74.89 B(+0.9%) |
| Sep 2019 | - | $74.20 B(-7.7%) |
| Jun 2019 | - | $80.41 B(+3.6%) |
| Mar 2019 | $77.62 B(+294.9%) | $77.62 B(+130.0%) |
| Dec 2018 | - | $33.75 B(+82.5%) |
| Sep 2018 | - | $18.50 B(-2.3%) |
| Jun 2018 | - | $18.94 B(-3.7%) |
| Mar 2018 | $19.66 B(-8.3%) | $19.66 B(-2.6%) |
| Dec 2017 | - | $20.19 B(+0.1%) |
| Sep 2017 | - | $20.18 B(-2.1%) |
| Jun 2017 | - | $20.61 B(-3.9%) |
| Mar 2017 | $21.45 B(+33.0%) | $21.45 B(+18.9%) |
| Dec 2016 | - | $18.04 B(-5.1%) |
| Sep 2016 | - | $19.00 B(+0.3%) |
| Jun 2016 | - | $18.95 B(+17.5%) |
| Mar 2016 | $16.13 B | $16.13 B(-4.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | - | $16.83 B(-0.7%) |
| Sep 2015 | - | $16.94 B(-0.5%) |
| Jun 2015 | - | $17.03 B(-2.2%) |
| Mar 2015 | $17.41 B(-11.7%) | $17.41 B(-0.0%) |
| Dec 2014 | - | $17.41 B(-6.6%) |
| Sep 2014 | - | $18.65 B(-4.6%) |
| Jun 2014 | - | $19.56 B(-0.8%) |
| Mar 2014 | $19.71 B(+8.3%) | $19.71 B(+4.9%) |
| Dec 2013 | - | $18.80 B(-3.5%) |
| Sep 2013 | - | $19.48 B(+15.8%) |
| Jun 2013 | - | $16.83 B(-7.6%) |
| Mar 2013 | $18.21 B(+4.2%) | $18.21 B(-5.8%) |
| Dec 2012 | - | $19.32 B(-0.7%) |
| Sep 2012 | - | $19.46 B(+1.8%) |
| Jun 2012 | - | $19.12 B(+9.4%) |
| Mar 2012 | $17.48 B(+123.8%) | $17.48 B(-6.1%) |
| Dec 2011 | - | $18.62 B(-1.8%) |
| Sep 2011 | - | $18.95 B(+156.1%) |
| Jun 2011 | - | $7.40 B(-5.3%) |
| Mar 2011 | $7.81 B(+10.9%) | $7.81 B(+8.3%) |
| Dec 2010 | - | $7.21 B(+1.5%) |
| Sep 2010 | - | $7.10 B(+4.8%) |
| Jun 2010 | - | $6.77 B(-3.8%) |
| Mar 2010 | $7.04 B(-1.3%) | $7.04 B(+1.3%) |
| Dec 2009 | - | $6.95 B(-4.0%) |
| Sep 2009 | - | $7.24 B(+1.5%) |
| Mar 2009 | $7.13 B(+35.3%) | $7.13 B(+1.8%) |
| Dec 2008 | - | $7.01 B |
| Mar 2008 | $5.27 B(+1.7%) | - |
| Mar 2007 | $5.18 B(-12.0%) | - |
| Mar 2006 | $5.89 B(+16.1%) | - |
| Mar 2005 | $5.08 B(-4.6%) | - |
| Mar 2004 | $5.32 B(+27.8%) | - |
| Mar 2003 | $4.17 B(+1.6%) | - |
| Mar 2002 | $4.10 B(+3.9%) | - |
| Mar 2001 | $3.95 B | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual total liabilities?
- What is the all time high annual total liabilities for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual total liabilities year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly total liabilities?
- What is the all time high quarterly total liabilities for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly total liabilities year-on-year change?
What is Takeda Pharmaceutical Company Limited annual total liabilities?
The current annual total liabilities of TAK is $51.76 B
What is the all time high annual total liabilities for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual total liabilities is $77.62 B
What is Takeda Pharmaceutical Company Limited annual total liabilities year-on-year change?
Over the past year, TAK annual total liabilities has changed by -$5.30 B (-9.28%)
What is Takeda Pharmaceutical Company Limited quarterly total liabilities?
The current quarterly total liabilities of TAK is $48.95 B
What is the all time high quarterly total liabilities for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly total liabilities is $80.41 B
What is Takeda Pharmaceutical Company Limited quarterly total liabilities year-on-year change?
Over the past year, TAK quarterly total liabilities has changed by -$4.62 B (-8.62%)